CCCC
C4 Therapeutics, Inc.
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$1.89
$-0.12
(-5.97%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $183.17M | EPS (ttm) | $-1.67 | Current Price | $1.89 |
| Enterprise Value | $52.75M | Forward EPS | $-1.29 | Previous Close | $2.01 |
| P/E Ratio | - | ROA | -23.20% | 52W High | $3.72 |
| Forward P/E | -1.47 | ROE | -59.98% | 52W Low | $1.08 |
| PEG Ratio | - | Gross Margin | -271.23% | 50 Day Avg | $2.25 |
| P/S Ratio | 6.08 | Operating Margin | -210.86% | 200 Day Avg | $2.13 |
| P/B Ratio | 0.91 | Profit Margin | - | Volume | 1.12M |
| EV/EBITDA | -0.45 | Current Ratio | 5.75 | Avg Volume | 1.62M |
| EV/Sales | 1.75 | Quick Ratio | 5.52 | Beta | 2.95 |
| Employees | 110.00 | Debt/Equity | 39.81 | Shares Outstanding | 96.91M |
| Sector | Healthcare | Total Debt | $61.46M | Float Shares | 61.74M |
| Industry | Biotechnology | Total Cash | $191.88M | Short Float | 8.05% |
| Optionable | - | Cash/Share | $1.98 | Short Ratio | 4.40 |
| Dividend Yield | - | Book Value/Share | $2.08 | % Held by Insiders | 7.20% |
| Target Price | $9.86 | Revenue (TTM) | $30.11M | % Held by Institutions | 73.79% |